👩💻 A new artificial intelligence can predict epileptic seizures one hour ahead of time with 99.6% accuracy
The system will give people suffering from epilepsy warning that a seizure is imminent, enabling them to take medication—or alert a friend, relative or medical professional.
🌳 New $10 million competition launched for preserving rainforests
XPRIZE is the global leader in designing and operating incentive competitions. The latest competion will help us find ways to preserve rainforests.
🛰️ Ozone hole is the smallest on record since its discovery
Researchers at the British Antarctic Survey discovered the ozone hole in 1985.
🔬 After more than two decades of research, the world finally has an approved Ebola vaccine
Ebola vaccine approved in Europe in landmark moment in fight against a deadly disease.
👩⚕️ An AI helps diagnose cervical cancer faster
Microsoft and SRL Diagnostics have developed an AI tool that helps detect cervical cancer.
Volkswagen invests $50 billion in electric vehicles
🔋🚘 Volkswagen has 70 electric vehicles in the pipeline, but first is an electric hatchback called ID.3. Priced from around $30,000 with a range of 200 miles or more. It will begin rolling off German assembly lines in November.
A carbon-negative vodka company makes its beverage literally out of thin air
🍹 The chemist Stafford Sheehan worked on artificial photosynthesis that creates renewable fuel made from air. One of the fuels he was making was ethanol.
Scientist plan a new mission to Pluto, now to orbit the planet
🛰️ NASA’s New Horizons mission taught us a lot about Pluto, but the spacecraft sped past so quickly. The next step is an orbiter, and now NASA is starting to seriously consider one. NASA has given theSouthwest Research Institute [https://www.swri.org/](SwRI) funding to start developing the idea.
Vaccine against 1.5 million killer tuberculosis is a step closer
💉 Tuberculosis kills 1.5 million people around the world each year. This vaccine could revolutionize treatment and provide long-term protection. It has already cleared a critical phase of clinical trials and been tested on more than 3,500 adults in TB endemic regions of South Africa, Kenya and Zambia, researchers